Spi-Poz-202
Research payments
$457,139
Through program year 2019, $457,139 in research payments was reported against Spi-Poz-202, across 120 payments, paid by Spectrum Pharmaceuticals Inc..
- Paid by
- Spectrum Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $457,139 | 120 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Nishan Tchekmedyian Irvine, CA Named on 11 payments
- David Chu E Setauket, NY Named on 9 payments
- Haiying Cheng Bronx, NY Named on 8 payments
- Elaine Shum New York, NY Named on 7 payments
- Jorge Nieva Los Angeles, CA Named on 6 payments
- Zofia Piotrowska Boston, MA Named on 5 payments
- Jeffrey Clarke Durham, NC Named on 4 payments
- Fabio Volterra Port Jefferson Station, NY Named on 4 payments
- Julie Brahmer Baltimore, MD Named on 4 payments
- Grace Dy Buffalo, NY Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.